UNSPSC 51422111: Clocortolone acetate

This classification denotes a therapeutic glucocorticoid C24H30ClFO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 85061HTR8T, chemically known as pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9-chloro-6-fluoro-11-hydroxy-16-methyl-, (6.alpha.,11.beta.,16.alpha.)-, but more generally known as clocortolone acetate, which bears US NIH Compound Identifier 3037082. Most nations, for tariff and trade purposes, schedule clocortolone acetate under HS 29372200 and SITC 54153.

As of Q4 2014, CLOCORTOLONE ACETATE remains US FDA's Preferred Term for this commodity. Clocortolone acetate bears US NLM identifiers UMLS ID C0770567 and NCI Concept Code C77410. SMILES: C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)COC(=O)C)C)O)CL)C)F.

UNSPSC 51422111 Clocortolone acetate is a Commodity code that nominally describes a topical corticosteroid pharmaceutical, but recent state and local procurement activity under this code shows a significant mismatch: the primary posted opportunity is Seminole County, Florida's IFB 60459723LAS, which solicits naloxone (an opioid antagonist) and safe drug deactivation systems rather than clocortolone acetate. State and local governments do not appear to be actively sourcing clocortolone acetate through publicly posted opportunities; this code shows little relevant recent activity aligned with its pharmaceutical scope.

The single recent solicitation on record—Seminole County's naloxone and drug deactivation systems IFB, posted June 30, 2026, with response due July 26, 2023—represents a public-health harm-reduction initiative rather than a pharmaceutical procurement within the code's stated product family. Seminole County is seeking 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract includes a two-year initial term with a one-year renewal option, fixed-fee pricing, and potential FEMA funding. Without additional recent opportunities specifically targeting clocortolone acetate or similar corticosteroid products under this Commodity code, the evidence does not support active state and local market demand for procurement under this classification.